Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

1.060 -0.030 (-2.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AN2 Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
AN2 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business and Scientific Highlights
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Present at Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics Signs License Agreement with the University of Georgia Research Foundation to Develop Novel Boron-Based Therapy for Chagas Disease
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics Signs Grant Agreement to Discover Novel, Boron Based Therapies for Tuberculosis and Malaria
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics commences Phase 3 Part of Phase 2/3 Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium avium complex (MAC) Lung Disease
From AN2 Therapeutics, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Fall Off A Cliff
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
$16M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mostly lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
AN2 Therapeutics Announces Pricing of $70.0 Million Underwritten Offering of Common Stock
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Present at Jefferies Healthcare Conference
From AN2 Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
AN2 Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Present at JMP Securities Life Sciences Conference
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Participate in Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
From AN2 Therapeutics, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Dip
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock
  Keybanc boosted the price target on Lennar Corporation (NYSE: LEN) from $89 to $100. Lennar shares fell 0.4% to close at $88.03 on Friday. 
Via Benzinga
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From AN2 Therapeutics, Inc.
Via GlobeNewswire
AN2 Therapeutics to Present at Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via GlobeNewswire
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
From AN2 Therapeutics, Inc.
Via GlobeNewswire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease
From AN2 Therapeutics, Inc.
Via GlobeNewswire
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million
NIAID Agreement to Advance Development of Epetraborole for Acute Systemic Melioidosis 
From AN2 Therapeutics, Inc.
Via GlobeNewswire
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Gainers 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.